|Articles|September 15, 2006

Express Report - New Directions and Options for the Management of Hypertension
Volume 12
Issue 1 Express

Valsartan Reduces Inflammatory Marker Associated with Hypertensive and Comorbid Risk; Effect Neutralized by Thiazide Diuretic

Download PDF: Valsartan Reduces Inflammatory Marker Associated with Hypertensive and Comorbid Risk; Effect Neutralized by Thiazide Diuretic

Articles in this issue

over 19 years ago

Article

Introduction

over 19 years ago

Article

New Direct Renin Inhibitor as Monotherapy or in Combination with Hydrochlorothiazide Controls Blood Pressure

over 19 years ago

Article

The Impact of Fixed-dose Combinations on Blood Pressure Control, Persistence, and Comorbid Disease

over 19 years ago

Article

Ability to Control Blood Pressure and Choice of Antihypertensive Impact Development and Course of Comorbid Disease

over 19 years ago

Article

Initial Drug Choice and Economics Affect Healthcare Utilization and Persistence

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

ByBimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Miranda R. Polin, MS, BS,Irl B. Hirsch, MD,Laya Ekhlaspour, MD,Steve Edelman, MD,Diana I. Brixner, PhD, RPh,Charles Stemple, DO

December 22nd 2025

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

ByPamela S. Roberts, PhD, OTR/L,Chih-Ying Li, PhD, OTR/L,Debra S. Ouellette, MS, OTR/L,Nabeel Qureshi, MPH,Erica Spivack, MHA,Mary Nasmyth, MD,Nancy L. Sicotte, MD,Zaldy S. Tan, MD

December 22nd 2025

Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures

ByJoshua R. Vest, PhD, MPH,Christopher A. Harle, PhD,Justin Blackburn, PhD

December 19th 2025

Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Katarzyna Rodchenko, MA, MPH,Lauren Isenman, MPH,Xue Han, PhD,Deborah Freedman, MBA,Rashmi Patel, MD, PhD

December 17th 2025

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

ByGury K. Doshi, MD,Lucio Gordan, MD,Kirollos Hanna, PharmD,Scott Freeswick, PharmD,Natalie Dickson, MD,Desi Kotis, PharmD,Osama Abdelghany, PharmD, MHA,Ken Komorny, PharmD,Neal Dave, PharmD,Michael Reff, RPh, MBA

December 16th 2025

Valsartan Reduces Inflammatory Marker Associated with Hypertensive and Comorbid Risk; Effect Neutralized by Thiazide Diuretic

Articles in this issue

Newsletter

Related Content

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures

Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

Trending on AJMC

Top 5 Most-Read HIV Articles of 2025

New Evidence Shows Exercise Could Ease Key Symptoms of Ovarian Cancer

Sleep Apnea Risk Tied to 40% Higher Odds of Poor Mental Health

ICYMI: Highlights From ASH 2025

Time-Limited Regimens Gain Notice, Offering a Break for Patients With Blood Cancer and Savings for Payers